Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Is there a higher risk of stent thrombosis in bifurcation lesion or is it related to the technique?

Iakovou I, Kadota K, Papamentzelopoulos S, Pavlides G, Mitsudo K.

EuroIntervention. 2010 Dec;6 Suppl J:J107-11. doi: 10.4244/EIJV6SUPJA17. Review.

PMID:
21930473
2.

Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.

De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F.

Catheter Cardiovasc Interv. 2011 May 1;77(6):765-72. doi: 10.1002/ccd.22899. Epub 2011 Mar 16.

PMID:
21413124
3.

Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.

Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K; j-Cypher Registry Investigators.

EuroIntervention. 2011 Sep;7(5):588-96. doi: 10.4244/EIJV7I5A95.

4.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
5.

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.

Waksman R, Pakala R.

EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6. Review.

PMID:
22100674
6.

Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results.

Jensen JS, Galløe A, Lassen JF, Erglis A, Kumsars I, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Thuesen L; Nordic-Baltic PCI Study Group.

EuroIntervention. 2008 Aug;4(2):229-33.

PMID:
19110788
7.

Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials.

Zhang F, Dong L, Ge J.

Heart. 2009 Oct;95(20):1676-81. doi: 10.1136/hrt.2009.168641. Epub 2009 Jul 29. Review.

PMID:
19643768
8.

Stent thrombosis--risk assessment and prevention.

Motovska Z, Knot J, Widimsky P.

Cardiovasc Ther. 2010 Oct;28(5):e92-100. doi: 10.1111/j.1755-5922.2010.00186.x. Epub 2010 Jun 11. Review.

PMID:
20553282
9.

Bifurcation disease: what do we know, what should we do?

Latib A, Colombo A.

JACC Cardiovasc Interv. 2008 Jun;1(3):218-26. doi: 10.1016/j.jcin.2007.12.008. Review.

10.

Stent thrombosis after percutaneous coronary intervention for bifurcation lesions.

Tan HC.

J Interv Cardiol. 2009 Apr;22(2):114-6. doi: 10.1111/j.1540-8183.2009.00438.x.

PMID:
19379468
11.

Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".

Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):976-83.

PMID:
17295334
12.

The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.

Lefèvre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B, Brunel P, Wijns W, Buettner HJ, Hartmann F, Veldhof S, Miquel K, Su X, van der Giessen WJ.

J Am Coll Cardiol. 2005 Aug 16;46(4):592-8.

13.

TheTryton side branch stent.

Magro M, van Geuns RJ.

EuroIntervention. 2010 Dec;6 Suppl J:J147-50. doi: 10.4244/EIJV6SUPJA25.

PMID:
21930481
14.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
15.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

Syed AI, Ben-Dor I, Li Y, Collins SD, Torguson R, Wakabayashi K, Gonzalez MA, Maluenda G, Delhaye C, Belle L, Gaglia MA Jr, Xue Z, Kaneshige K, Bernardo N, Kent KM, Suddath WO, Satler LF, Pichard AD, Lindsay J, Waksman R.

EuroIntervention. 2011 Apr;6(9):1085-90. doi: 10.4244/EIJV6I9A189.

PMID:
21518681
16.

Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.

Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA, Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH.

Circulation. 2010 Mar 16;121(10):1235-43. doi: 10.1161/CIRCULATIONAHA.109.888297. Epub 2010 Mar 1.

17.

Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS).

Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi-Zoccai GG, Sangiorgi G; I-BIGIS Study Group Milan, Italy.

Am Heart J. 2010 Sep;160(3):535-542.e1. doi: 10.1016/j.ahj.2010.06.028.

PMID:
20826264
18.

Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS; ARRIVE 1 and ARRIVE 2 Participating Physicians.

Circ Cardiovasc Interv. 2009 Aug;2(4):285-93. doi: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. Epub 2009 Jul 22.

19.

Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.

Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.

Minerva Cardioangiol. 2008 Feb;56(1):35-42.

PMID:
18432167
20.

Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry.

Burzotta F, Sgueglia GA, Trani C, Talarico GP, Coroleu SF, Giubilato S, Niccoli G, Giammarinaro M, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F.

J Invasive Cardiol. 2009 Oct;21(10):532-7.

PMID:
19805841

Supplemental Content

Support Center